INFLAMMATION
INFLAMMATION, licence 80038016: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Distripharm Inc.
- NPN or DIN-HM
- 80038016
- Status
- Active licence
- Licence date
- 30 November 2012
- Revision date
- 13 October 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Résine Potency : 70.0 % Acide boswellique | 75.0 mg | Not calculated |
| Curcuma longa Source : Rhizome Extraction ratio : 20:1 Dry plant equivalent : 1500 mg | 75.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Cellulose, microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Utilisé traditionnellement en phytothérapie/herboristerie comme anti-inflammatoire pour aider à soulager la douleur articulaire.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser en cas d'allergie à l'ananas. Consulter un praticien en soins de santé: Si vous avez un historique médical de calculs biliaires; Si vous souffrez d'obstruction biliaire et/ou d'ulcères d'estomac. Ne pas utiliser si vous êtes enceintes ou allaitez. Tenir hors de la portée des enfants. Consulter un praticien de soins de santé avant d'en faire l'usage, si vous souffrez d'un excès d'acide gastrique, de lésions gastro-intestinales, prenez des anticoagulants, des anti-inflammatoires ou des antibiotiques ou avant de subir une chirurgie. De la nausée, des vomissements et de la diarrhée peuvent se manifester. Si tel est le cas, cesser l'utilisation et consulter un praticien de soins de santé. Une hypersensibilité/allergie peut se manifester. Si tel est le cas, cesser l'utilisation. Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent.
- Contre-indications
Ne pas utiliser avec des anti-coagulants, des antiplaquettaires, des antibiotiques et des tétracyclines.
Source
Official Health Canada record, licence 80038016
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.